Authors:
Ryo, A
Nakamura, M
Wulf, G
Liou, YC
Lu, KP
Citation: A. Ryo et al., Pin 1 regulates turnover and subcellular localization of beta-catenin by inhibiting its interaction with APC, NAT CELL BI, 3(9), 2001, pp. 793-801
Citation: S. Kishi et al., Telomeric protein Pin2/TRF1 induces mitotic entry and apoptosis in cells with short telomeres and is down-regulated in human breast tumors, ONCOGENE, 20(12), 2001, pp. 1497-1508
Citation: Nh. Mcnevin et al., Effects of attentional focus, self-control, and dyad training on motor learning: Implications for physical rehabilitation, PHYS THER, 80(4), 2000, pp. 373-385
Citation: G. Wulf et T. Toole, Physical assistance devices in complex motor skill learning: Benefits of aself-controlled practice schedule, RES Q EXERC, 70(3), 1999, pp. 265-272
Citation: G. Wulf et al., Learning phenomena: Future challenges for the dynamical systems approach to understanding the learning of complex motor skills, INT J SP PS, 30(4), 1999, pp. 531-557
Citation: Pj. Lu et al., The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein, NATURE, 399(6738), 1999, pp. 784-788
Authors:
Diehl, V
Franklin, J
Hasenclever, D
Tesch, H
Pfreundschuh, M
Lathan, B
Paulus, U
Sieber, M
Ruffer, JU
Sextro, M
Engert, A
Wolf, J
Hermann, R
Holmer, L
Stappert-Jahn, U
Winnerlein-Trump, E
Wulf, G
Krause, S
Glunz, A
von Kalle, K
Bischoff, H
Haedicke, C
Duhmke, E
Georgii, A
Loeffler, M
Citation: V. Diehl et al., BEACOPP: A new regimen for advanced Hodgkin's disease, ANN ONCOL, 9, 1998, pp. 67-71
Authors:
Diehl, V
Franklin, J
Hasenclever, D
Tesch, H
Pfreundschuh, M
Lathan, B
Paulus, U
Sieber, M
Rueffer, JU
Sextro, M
Engert, A
Wolf, J
Hermann, R
Holmer, L
Stappert-Jahn, U
Winnerlein-Trump, E
Wulf, G
Krause, S
Glunz, A
von Kalle, K
Bischoff, H
Haedicke, C
Duehmke, E
Georgii, A
Loeffler, M
Citation: V. Diehl et al., BEACOPP, a new dose-escalated and accelerated regimen, is at least as effective as COPP/ABVD in patients with advanced-stage Hodgkin's lymphoma: Interim report from a trial of the German Hodgkin's Lymphoma Study Group, J CL ONCOL, 16(12), 1998, pp. 3810-3821
Authors:
Tesch, H
Diehl, V
Lathan, B
Hasenclever, D
Sieber, M
Ruffer, U
Engert, A
Franklin, J
Pfreundschuh, M
Schalk, KP
Schwieder, G
Wulf, G
Dolken, G
Worst, P
Koch, P
Schmitz, N
Bruntsch, U
Tirier, C
Muller, U
Loeffler, M
Citation: H. Tesch et al., Moderate dose escalation for advanced stage Hodgkin's disease using the bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone scheme and adjuvant radiotherapy: A study of the German Hodgkin's Lymphoma Study Group, BLOOD, 92(12), 1998, pp. 4560-4567